Raph L Hamers

8.4k total citations · 1 hit paper
103 papers, 2.9k citations indexed

About

Raph L Hamers is a scholar working on Infectious Diseases, Virology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Raph L Hamers has authored 103 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Infectious Diseases, 54 papers in Virology and 17 papers in Applied Microbiology and Biotechnology. Recurrent topics in Raph L Hamers's work include HIV/AIDS Research and Interventions (58 papers), HIV Research and Treatment (54 papers) and HIV/AIDS drug development and treatment (52 papers). Raph L Hamers is often cited by papers focused on HIV/AIDS Research and Interventions (58 papers), HIV Research and Treatment (54 papers) and HIV/AIDS drug development and treatment (52 papers). Raph L Hamers collaborates with scholars based in Netherlands, United Kingdom and Indonesia. Raph L Hamers's co-authors include Tobias F. Rinke de Wit, Cissy Kityo, Kim Sigaloff, Wendy Stevens, Margaret Siwale, Kishor Mandaliya, Carole L. Wallis, Rob Schuurman, Michèle van Vugt and Mariëtte E. Botes and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Raph L Hamers

92 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WHO global research priorities for antimicrobial resistance in human health

2024 68 citations Silvia Bertagnolio, Ioana D. Olaru et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raph L Hamers Netherlands	32	2.4k	1.9k	585	207	152	103	2.9k
Silvia Bertagnolio Switzerland	34	3.2k 1.3×	2.3k 1.2×	922 1.6×	242 1.2×	209 1.4×	99	3.9k
John N. Nkengasong United States	33	2.2k 0.9×	1.3k 0.7×	957 1.6×	279 1.3×	61 0.4×	95	3.3k
Sinata Koulla‐Shiro Cameroon	28	1.4k 0.6×	564 0.3×	758 1.3×	315 1.5×	68 0.4×	89	2.0k
Philippe Clevenbergh France	19	1.4k 0.6×	1.0k 0.6×	492 0.8×	67 0.3×	258 1.7×	63	2.2k
Renaud Verdon France	26	1.4k 0.6×	500 0.3×	735 1.3×	134 0.6×	98 0.6×	111	2.4k
Kim Sigaloff Netherlands	26	2.0k 0.9×	1.5k 0.8×	535 0.9×	132 0.6×	37 0.2×	76	2.2k
Frank van Leth Netherlands	27	2.1k 0.9×	817 0.4×	1.0k 1.8×	138 0.7×	127 0.8×	107	2.7k
Antonio Di Biagio Italy	26	1.7k 0.7×	984 0.5×	695 1.2×	65 0.3×	104 0.7×	263	2.8k
Lutgarde Lynen Belgium	33	2.2k 1.0×	628 0.3×	1.9k 3.3×	292 1.4×	40 0.3×	177	4.2k
Mark F. Cotton South Africa	24	1.6k 0.7×	414 0.2×	988 1.7×	397 1.9×	79 0.5×	116	2.5k

Countries citing papers authored by Raph L Hamers

Since Specialization

Citations

This map shows the geographic impact of Raph L Hamers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raph L Hamers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raph L Hamers more than expected).

Fields of papers citing papers by Raph L Hamers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raph L Hamers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raph L Hamers. The network helps show where Raph L Hamers may publish in the future.

Co-authorship network of co-authors of Raph L Hamers

This figure shows the co-authorship network connecting the top 25 collaborators of Raph L Hamers. A scholar is included among the top collaborators of Raph L Hamers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raph L Hamers. Raph L Hamers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bøgh, Claus, Annemieke Geluk, J. Kevin Baird, et al.. (2025). Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs. The Lancet Regional Health - Southeast Asia. 34. 100555–100555.

Vu, Dung Tien Viet, et al.. (2025). Research Electronic Data Capture (REDCap) for Population-Based Data Collection in Low- and Middle-Income Countries: Opportunities, Challenges, and Solutions. Journal of Medical Internet Research. 27. e65377–e65377.

Djaafara, Bimandra A, Iqbal Elyazar, Raph L Hamers, et al.. (2025). Modeling the transmission dynamics and control strategies during the 2017 diphtheria outbreak in Jakarta, Indonesia. Infectious Disease Modelling. 11(1). 1–15.

Hamers, Raph L, Kevin Baird, Iqbal Elyazar, et al.. (2024). A description of lineage 1 Mycobacterium tuberculosis from papua, Indonesia. Tuberculosis. 149. 102568–102568.

Sinto, Robert, Suhendro Suwarto, Erni Juwita Nelwan, et al.. (2024). Diagnostic and antibiotic use practices among COVID-19 and non-COVID-19 patients in the Indonesian National Referral Hospital. PLoS ONE. 19(3). e0297405–e0297405. 3 indexed citations

Hamers, Raph L, Alessandro Cassini, Alice Tamara, et al.. (2023). Global knowledge gaps on antimicrobial resistance in the human health sector: A scoping review. International Journal of Infectious Diseases. 134. 142–149. 14 indexed citations

Surendra, Henry, Ngabila Salama, Karina D. Lestari, et al.. (2022). Pandemic inequity in a megacity: a multilevel analysis of individual, community and healthcare vulnerability risks for COVID-19 mortality in Jakarta, Indonesia. BMJ Global Health. 7(6). e008329–e008329. 13 indexed citations

Sinto, Robert, Suhendro Suwarto, Erni Juwita Nelwan, et al.. (2022). Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital. Antimicrobial Resistance and Infection Control. 11(1). 73–73. 21 indexed citations

Hamers, Raph L, et al.. (2022). Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review. BMJ Open. 12(6). e060553–e060553. 5 indexed citations

10.

Huong, Vu Thi Lan, Raph L Hamers, Ralalicia Limato, et al.. (2022). Identifying context-specific domains for assessing antimicrobial stewardship programmes in Asia: protocol for a scoping review. BMJ Open. 12(9). e061286–e061286.

11.

Limato, Ralalicia, L Gilbert, Erni Juwita Nelwan, et al.. (2022). Optimizing antibiotic use in Indonesia: a systematic review and synthesis of current evidence to inform opportunities for intervention. medRxiv. 1 indexed citations

12.

Limato, Ralalicia, et al.. (2021). A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals. JAC-Antimicrobial Resistance. 3(2). dlab047–dlab047. 30 indexed citations

13.

Crevel, Reinout van, Julián Ávila-Pacheco, Nguyễn Thụy Thương Thương, et al.. (2021). Improving host-directed therapy for tuberculous meningitis by linking clinical and multi-omics data. Tuberculosis. 128. 102085–102085. 6 indexed citations

14.

Bijker, Rimke, Awachana Jiamsakul, Cissy Kityo, et al.. (2017). Adherence to antiretroviral therapy for HIV in sub‐Saharan Africa and Asia: a comparative analysis of two regional cohorts. Journal of the International AIDS Society. 20(1). 21218–21218. 60 indexed citations

15.

Revell, Andrew, Raph L Hamers, Roos E. Barth, et al.. (2013). Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings. Antiviral Therapy. 18. 1 indexed citations

16.

Hamers, Raph L, Kim Sigaloff, Annemarie M. J. Wensing, et al.. (2012). Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies. Clinical Infectious Diseases. 54(11). 1660–1669. 137 indexed citations

17.

Sigaloff, Kim, Raph L Hamers, Carole L. Wallis, et al.. (2011). Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 23–31. 151 indexed citations

18.

Sigaloff, Kim, Kishor Mandaliya, Raph L Hamers, et al.. (2011). Short Communication: High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya. AIDS Research and Human Retroviruses. 28(9). 1033–1037. 33 indexed citations

19.

Hamers, Raph L, Margaret Siwale, Carole L. Wallis, et al.. (2010). HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 95–101. 31 indexed citations

20.

Hamers, Raph L, Rob Schuurman, Michèle van Vugt, Inge Derdelinckx, & Tobias F. Rinke de Wit. (2007). [AIDS treatment in Africa: the risk of antiretroviral resistance].. PubMed. 151(48). 2666–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact